Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
With this, the company can start selling Ibuprofen in the European markets.
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Subscribe To Our Newsletter & Stay Updated